Hence, it is hypothesised that while the adjacent normal cells in the stage II and stage III HNSCC patients had elevated APE1 expression, they also upregulated BRCA2 and XPD expression under the influence of the tumour cells in an effort to suppress their own carcinogenic transformation. This evidence concerns the gene ERCC2 and head and neck squamous cell carcinoma.